Yenealem Temesgen-Oyelakin, BSN, RN
https://www.niams.nih.gov/es/node/1617
Yenealem is interested in Clinical Trial research to find new and better ways to treat Lupus patients.
Displaying 241 - 260 of 1020 results
Elizabeth Elliott
https://www.niams.nih.gov/es/node/1618
Elizabeth Elliott, Ethics Coordinator, Office of the Director
Xuesong Feng, Ph.D.
https://www.niams.nih.gov/es/node/1628
Xuesong Feng is a Staff Scientist in the Laboratory of Muscle Stem Cells and Gene Regulation.
Hong-Wei Sun, Ph.D.
https://www.niams.nih.gov/es/node/1630
As head of the Biodata Mining and Discovery Section, Dr. Sun focuses on applying computational approaches of data sciences to biomedical research.
Judith Spector
https://www.niams.nih.gov/es/node/1651
Judith Spector is an Extramural Support Specialist in the Scientific Review Branch at NIAMS.
James Simone
https://www.niams.nih.gov/es/node/1654
Mr. Simone oversees and manages the NIAMS Flow Cytometry core facility. The facility provides state-of-the-art services, including cell sorting, training, guidance for cytometry data analysis, and scientific project consultation for NIAMS researchers.
Pravitt Gourh, M.D.
https://www.niams.nih.gov/es/node/1664
Dr. Gourh is a board-certified rheumatologist with a long-standing interest in scleroderma, and currently directs a translational research program focused on understanding the genetics of scleroderma, biomarker discovery, and disease classification.
Susana A. Serrate-Sztein, M.D.
https://www.niams.nih.gov/es/node/1674
Susana A. Serrate-Sztein, M.D., Senior Advisor to the Director
Sarfaraz Hasni, M.D.
https://www.niams.nih.gov/es/node/1677
Dr. Sarfaraz Hasni is a clinician, a faculty of the Rheumatology Fellowship Training Program and chief of Lupus clinical trials.
Kathy Salaita, Sc.D.
https://www.niams.nih.gov/es/node/1690
Kathy Salaita, Sc.D., is Chief of the Scientific Review Branch, and she is responsible for the supervisory management and oversight of the Scientific Review Branch and strategic planning activities as relevant to the peer review process.
Director’s Message
https://www.niams.nih.gov/es/node/15656
The NIAMS Strategic Plan for FY 2025–2029 focuses on advancing therapy, fostering discoveries, supporting research infrastructure, and communicating health advances from the Director.
Strategic Plan Framework
https://www.niams.nih.gov/es/node/15661
NIAMS Strategic Plan FY 2025–2029 advances research in arthritis, musculoskeletal, and skin diseases, focusing on innovation, equity, collaboration, and workforce diversity.
Introduction
https://www.niams.nih.gov/es/node/15666
NIAMS, established in 1986, supports research on arthritis, musculoskeletal, and skin diseases, aiming for transformative research and equitable health outcomes.
Bold Aspirations
https://www.niams.nih.gov/es/node/15671
NIAMS aims for advances in disease understanding, personalized treatments, data science, digital health, and addressing health disparities over the next five years.